The body temperature of all patients upon arrival at endoscopy units, clinics or inpatient wards should be checked and documented. All admissions to hospital should be screened for COVID-19 by chest computed tomography (CT) scan and be confirmed by real-time reverse-transcriptase polymerase chain reaction (RT-PCR) assay for nasal and pharyngeal swab specimens. COVID-19 should be diagnosed on the basis of the WHO interim guidance. Isolation precautions should be taken for those awaiting test results.([FOOTNOTE= https://link.springer.com/article/10.1007/s11695-020-04578-1],[ANCHOR=],[LINK=])
All patients should be asked about recent history of fever or respiratory symptoms, family members or close contacts with similar symptoms, any contact with a confirmed case of COVID-19 and recent travel to high-risk areas.
During this time when GI societies have recommended delaying elective procedures([FOOTNOTE=ESGE and ESGENA Position Statement on gastrointestinal endoscopy and the COVID-19 pandemic (https://www.esge.com/assets/downloads/pdfs/general/ESGE_ESGENA_Position_Statement_gastrointestinal_endoscopy_COVID_19_pandemic.pdf) ],[ANCHOR=],[LINK=]), we would like to share how the PillCam™capsule endoscopy (CE) platform can help alleviate the burden on hospitals while supporting efficient patient management.
If you cannot find what you’re looking for, please fill in our Contact Us form by clicking on the link below.